Supplements Manufacturer π retweeted
Going live in a bit gonna give away a few hundred bucks because this market sucks so bad.
Come join the fun.
Ocugen CEO @drsmusunuri joined @BBC Correspondent @JamesTGallagher at Cell & Gene Leaders Live to discuss our modifier gene therapy platform and its potential to address vision loss across a broader patient population.
#GeneTherapy #Biotech $OCGN
Supplements Manufacturer π retweeted
$OCGN #OCUGEN π π π
I wander how @drsmusunuri does this, this weekend in London....
Thank you @drsmusunuri !
Supplements Manufacturer π retweeted
$OCGN is targeting some of the biggest markets in biotech, with remarkable efficacy, a exceptional safety profile, hundreds of genetic mutations addressed with a single therapy, markets with little to no effective treatment options, a platform set to keep expanding with back to back pivotal results and commercialization right around the corner.
The markets are what they are, the numbers are what they are. Hell, I was breaking down these drugs numbers years ago showcasing the trillion dollar market potential youβre now seeing presented on the companyβs slides.
My point is, if youβre buying this stock today, youβre buying what is clearly going to become one of the largest and most profitable biotech companies in history, before everyone else realizes it.
If youβve ever wondered what it wouldβve been like to buy into one of the giants of an industry at the ground floor, right before the steady rise to market leaders, well, youβre looking at one of those opportunities right now. Itβs beyond obvious. π»
$ocgn Most will see βPhase 3 for GA in 2026β and shrug. The ones who know GA, the therapy and this market understand the gravity of what was just announced.
Dr. Jay Chhablan the Vice Chair of Clinical Trials at the University of Pittsburgh Medical Center Vision Institute just said the 6 month OCU410 data already looks superior to the FDA approved drugs when he compared them side by side.
Retail needs to understand why this sets OCU410 up as one of the most valuable medicines ever lined up to hit the market.
Why Iβm saying that
OCU400 family keeps winning. OCU400 for IRDs, OCU410ST for Stargardt, and OCU410 for GA have shown consistent 100% efficacy signals with 100% safety to date. FDAβs recent CGT flexibility on self controlled designs external controls and registry follow up is also built for this platform and means a very fast path to market than anyone expects.
So why would OCU410 likely be the worldβs most valuable drug and why has big pharma paid billions for early phase GA assets?
Because the numbers are staggering.
ππ»πΈπ¦
$OCGN #OCUGEN π π π
I wander how @drsmusunuri does this, this weekend in London....
Thank you @drsmusunuri !
Supplements Manufacturer π retweeted
$OCGN #OCUGEN...from today's presentation.
Huge thank you to @drsmusunuri!
Itβs inspiring to see your dedication in action. So proud to have you at the helmβkeep up the amazing work! π
Supplements Manufacturer π retweeted
π¨ BREAKING: Elon Musk has OFFICIALLY been invited to relocate its Tesla headquarters from Texas to the free state of FLORIDA βοΈ
And the invite points STRAIGHT to the fact Democrats won Texas
Gov. Ron DeSantis has also warned that Elon may soon be TARGETED because of the election results
REP. CARLOS GIMENEZ: "While others seek to investigate and punish success, Florida welcomes it."
"I write to formally invite Tesla to consider relocating its corporate headquarters and expanding its operations from Texas to the free State of Florida, where innovation, entrepreneurship, and economic freedom are celebrated."
"With the recent election of self-described Democratic Socialists to positions of power in Texas, I share your concerns about excessive government interference, politically motivated investigations, and policies that punish success."
"No company should face political retaliation for creating jobs, investing in American innovation, and contributing to our nation's prosperity."
"The Sunshine State is open for business."
Musk already took his companies OUT of California because of hostile politics
If Texas starts heading down that same road, Florida is ready!
$OCGN #OCUGEN...from today's presentation.
Huge thank you to @drsmusunuri!
Itβs inspiring to see your dedication in action. So proud to have you at the helmβkeep up the amazing work! π
Today, at the @Stifel 2026 Healthcare Conference, Ocugen CEO @drsmusunuri highlighted our novel modifier #genetherapy platform and three Phase 3 investigational assets in NYC. #Biotech
Watch the replay: bit.ly/4zdvc2f
$OCGN
Supplements Manufacturer π retweeted
$OCGN #OCUGEN @Ocugen @drsmusunuri
Questions about partnering with a newly formed company instead of a major pharma are understandable. This is classic Dr. Musunuri 4D chess play: by teaming with a regional specialist built for Australia, New Zealand, Taiwan, and ASEAN
Ocugen unlocks 14 markets (~725 million people) while securing 50% of gross profits from OCU400 net sales β plus milestones and royalties β and keeps manufacturing rights. Local expertise and strong economics over pure scale.
Without giving up anything to BP.
π₯π₯π₯
$OCGN People see that Celairis isnβt a giant, lacks doctors or labs, and assume they canβt do anything.
Reality is, a guy with RP walks into an ophthalmology office, doc says thereβs an approved treatment, and he goes to a local surgeon to get dosed.
These arenβt development partnerships, theyβre licensing deals. Ocugen retains control/sole manufacturing rights. Celairis gets OCU400 approved in their territory.
The question isnβt whether Celairis can manufacture or perform surgery. Itβs whether they can get us approved.
Their CEO spent 11 years at Novartis as Country President for Australia/New Zealand, then ran Australiaβs largest pharma company. Iβd say heβs exactly who we need.
Ocugen isnβt selling out to BP. They know what they own, have commercial supply ready, and their drug uses existing surgical techniques.
The outcome is thousands of million dollar checks coming in globally for Ocugen to collect for the next 10+ years. π»
$OCGN #OCUGEN @Ocugen @drsmusunuri
Questions about partnering with a newly formed company instead of a major pharma are understandable. This is classic Dr. Musunuri 4D chess play: by teaming with a regional specialist built for Australia, New Zealand, Taiwan, and ASEAN
Ocugen unlocks 14 markets (~725 million people) while securing 50% of gross profits from OCU400 net sales β plus milestones and royalties β and keeps manufacturing rights. Local expertise and strong economics over pure scale.
Without giving up anything to BP.
π₯π₯π₯
$OCGN People see that Celairis isnβt a giant, lacks doctors or labs, and assume they canβt do anything.
Reality is, a guy with RP walks into an ophthalmology office, doc says thereβs an approved treatment, and he goes to a local surgeon to get dosed.
These arenβt development partnerships, theyβre licensing deals. Ocugen retains control/sole manufacturing rights. Celairis gets OCU400 approved in their territory.
The question isnβt whether Celairis can manufacture or perform surgery. Itβs whether they can get us approved.
Their CEO spent 11 years at Novartis as Country President for Australia/New Zealand, then ran Australiaβs largest pharma company. Iβd say heβs exactly who we need.
Ocugen isnβt selling out to BP. They know what they own, have commercial supply ready, and their drug uses existing surgical techniques.
The outcome is thousands of million dollar checks coming in globally for Ocugen to collect for the next 10+ years. π»
Supplements Manufacturer π retweeted
New Research Report: Ocugen (OCGN) β OCU400 Marketing Agreement For Australia, New Zealand, and ASEAN Announced
$OCGN #Ocugen #Investing #EquityResearch
channelchek.com/news-channelβ¦
Supplements Manufacturer π retweeted
New Research Report: Ocugen (OCGN) β OCU400 Marketing Agreement For Australia, New Zealand, and ASEAN Announced
$OCGN #Ocugen #Investing #EquityResearch
channelchek.com/news-channelβ¦






















